Literature DB >> 20180029

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

Stephen B Edge, Carolyn C Compton.   

Abstract

The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

Entities:  

Mesh:

Year:  2010        PMID: 20180029     DOI: 10.1245/s10434-010-0985-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  2000 in total

1.  Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.

Authors:  Allen S Ho; Lu Wang; Frank L Palmer; Changhong Yu; Arnbjorn Toset; Snehal Patel; Michael W Kattan; R Michael Tuttle; Ian Ganly
Journal:  Ann Surg Oncol       Date:  2014-11-04       Impact factor: 5.344

2.  Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.

Authors:  Chi Zhang; Li-Xin Liu; Zhao-Ru Dong; Guo-Ming Shi; Jia-Bin Cai; Peng-Fei Zhang; Ai-Wu Ke; Jing-Xian Yu; Jian Zhou; Jia Fan
Journal:  Tumour Biol       Date:  2014-11-13

3.  Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Honggang Xia; Lan Ma; Jing Li; Hongyu Bai; Dongbin Wang
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

4.  Long-Term Survival of Recurrent Intrahepatic Cholangiocarcinoma: The Impact and Selection of Repeat Surgery.

Authors:  Tomoaki Yoh; Etsuro Hatano; Satoru Seo; Yukihiro Okuda; Hiroaki Fuji; Yoshinobu Ikeno; Kojiro Taura; Kentaro Yasuchika; Hideaki Okajima; Toshimi Kaido; Shinji Uemoto
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

5.  Survival of patients with subglottic squamous cell carcinoma.

Authors:  S D MacNeil; K Patel; K Liu; S Shariff; J Yoo; A Nichols; K Fung; A X Garg
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

6.  Distinct Gene Expression Profiles Define Anaplastic Grade in Retinoblastoma.

Authors:  Lauren E Hudson; Pia Mendoza; William H Hudson; Alison Ziesel; G Baker Hubbard; Jill Wells; Bhakti Dwivedi; Jeanne Kowalski; Sandra Seby; Viren Patel; Eldon Geisert; Charles Specht; Hans E Grossniklaus
Journal:  Am J Pathol       Date:  2018-07-21       Impact factor: 4.307

Review 7.  Rectal carcinoids: a systematic review.

Authors:  Frank D McDermott; Anna Heeney; Danielle Courtney; Helen Mohan; Des Winter
Journal:  Surg Endosc       Date:  2014-03-01       Impact factor: 4.584

Review 8.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 9.  Management of pulmonary neuroendocrine tumors.

Authors:  Robert A Ramirez; Aman Chauhan; Juan Gimenez; Katharine E H Thomas; Ioni Kokodis; Brianne A Voros
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

10.  VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR.

Authors:  Cheng Liu; Li Liu; Kun Wang; Xiao-Feng Li; Li-Yuan Ge; Run-Zhuo Ma; Yi-Dong Fan; Lu-Chao Li; Zheng-Fang Liu; Min Qiu; Yi-Chang Hao; Zhen-Feng Shi; Chuan-You Xia; Klas Strååt; Yi Huang; Lu-Lin Ma; Dawei Xu
Journal:  Oncogene       Date:  2020-04-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.